Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
CRH
CRH
|
+$150M |
| 2 |
Kenvue
KVUE
|
+$98.9M |
| 3 |
Textron
TXT
|
+$50.7M |
| 4 |
Extra Space Storage
EXR
|
+$23.3M |
| 5 |
AngloGold Ashanti
AU
|
+$17.1M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.12B |
| 2 |
Microsoft
MSFT
|
+$890M |
| 3 |
Amazon
AMZN
|
+$463M |
| 4 |
NVIDIA
NVDA
|
+$425M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$316M |
Sector Composition
| 1 | Technology | 29.44% |
| 2 | Healthcare | 13.62% |
| 3 | Consumer Discretionary | 11.97% |
| 4 | Industrials | 9.13% |
| 5 | Communication Services | 8.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Walker & Dunlop
WD
$2.95B
| $5.17M | ﹤0.01% |
69,700
+800
| +1% | +$59.4K |
|
1252
Corcept Therapeutics
CORT
$7.62B
| $5.17M | ﹤0.01% |
189,765
+1,800
| +1% | +$49K |
|
1253
Knife River
KNF
$4.46B
| $5.16M | ﹤0.01% |
105,698
+400
| +0.4% | +$19.5K |
|
|
GAP
1254
The Gap, Inc.
GAP
$8.45B
| $5.16M | ﹤0.01% |
485,400
+44,900
| +10% | +$477K |
|
1255
Macerich
MAC
$4.59B
| $5.16M | ﹤0.01% |
472,815
+4,700
| +1% | +$51.3K |
|
1256
Werner Enterprises
WERN
$1.68B
| $5.15M | ﹤0.01% |
132,300
+1,200
| +0.9% | +$46.7K |
|
1257
CBIZ
CBZ
$3.04B
| $5.14M | ﹤0.01% |
99,100
+400
| +0.4% | +$20.8K |
|
1258
M/I Homes
MHO
$4.1B
| $5.14M | ﹤0.01% |
61,200
+3,900
| +7% | +$328K |
|
1259
Autohome
ATHM
$3.46B
| $5.14M | ﹤0.01% |
169,289
-9,200
| -5% | -$279K |
|
1260
BridgeBio Pharma
BBIO
$9.82B
| $5.12M | ﹤0.01% |
194,100
+2,300
| +1% | +$60.7K |
|
1261
Resideo Technologies
REZI
$5.67B
| $5.11M | ﹤0.01% |
323,400
+4,200
| +1% | +$66.4K |
|
1262
Marqeta
MQ
$2.61B
| $5.11M | ﹤0.01% |
854,100
+11,600
| +1% | +$69.4K |
|
1263
SITE Centers
SITC
$464M
| $5.11M | ﹤0.01% |
530,773
+5,127
| +1% | +$49.3K |
|
1264
Doximity
DOCS
$13.4B
| $5.1M | ﹤0.01% |
240,500
+7,900
| +3% | +$168K |
|
1265
Kohl's
KSS
$1.73B
| $5.1M | ﹤0.01% |
243,200
+2,100
| +0.9% | +$44K |
|
1266
CVB Financial
CVBF
$2.77B
| $5.07M | ﹤0.01% |
306,200
+2,900
| +1% | +$48.1K |
|
1267
RXO
RXO
$2.72B
| $5.07M | ﹤0.01% |
257,100
+2,600
| +1% | +$51.3K |
|
1268
First Hawaiian
FHB
$3.2B
| $5.06M | ﹤0.01% |
280,467
+2,500
| +0.9% | +$45.1K |
|
1269
InMode
INMD
$947M
| $5.04M | ﹤0.01% |
165,600
| – | – |
|
1270
Steven Madden
SHOO
$2.27B
| $5.04M | ﹤0.01% |
158,725
+1,500
| +1% | +$47.7K |
|
1271
Alight
ALIT
$1.94B
| $5.04M | ﹤0.01% |
711,000
+86,300
| +14% | +$612K |
|
1272
Hecla Mining
HL
$7.56B
| $5.03M | ﹤0.01% |
1,286,962
+41,400
| +3% | +$162K |
|
1273
RingCentral
RNG
$2.77B
| $5.02M | ﹤0.01% |
169,500
-7,400
| -4% | -$219K |
|
1274
Axsome Therapeutics
AXSM
$5.89B
| $5.01M | ﹤0.01% |
71,700
-4,100
| -5% | -$287K |
|
1275
Parsons
PSN
$8.19B
| $5.01M | ﹤0.01% |
92,200
+1,100
| +1% | +$59.8K |
|